bioRxivGenomicsPreprint
Skull base invasive low-grade meningiomas, a distinct genetic subgroup: A microarray gene expression profile analysis.
Jun SakumaiD, Masazumi FujiiiD, Yugo Kishida, Kenichiro IwamiiD, Keiko OdaiD, Kensho IwatateiD, Masahiro IchikawaiD, Mudathir S. BakhitiD, Taku SatoiD, Satoshi WaguriiD, Shinya WatanabeiD, Kiyoshi SaitoiD
Abstract
IntroductionMeningioma is the most common adult primary brain tumor originating from meningeal coverings of the brain and spinal cord. Commonly, World Health Organization (WHO) grade-I meningiomas are slowly growing and surgically curative, some present with clinically aggressive behavior, invading the skull base bone and soft tissues by extending into the extracranial spaces.\n\nMethodsTo detect the genetic background of the Skull Base Invasive Low-grade Meningioma (SBILM), we conducted a comprehensive analysis of gene expression was conducted on 32 meningioma samples.\n\nResultsThe cluster analysis of the gene expression profile demonstrated a distinctive clustering pattern of the SBILM. Based on the clinical behavior and the microarray findings, they might be a distinct subgroup of meningiomas.\n\nConclusionFurther studies on characterization of genes specifically expressed by the SBILM could lead to the development of diagnostic tools, differentiating it from other WHO grade-I meningiomas and assist in the appropriate management and follow-up strategy, and open the door for development of pharmacological therapies.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Homogenous subgroups of atypical meningiomas defined using oncogenic signatures: basis for a new grading system?
Z. Zador, A. Landry, … M. Cusimano·bioRxiv·Dec 14, 2018
- Skull base meningiomas have a distinct immune landscape.
Z. Zador, A. Landry, … M. Cusimano·bioRxiv·Jan 20, 2019
- Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion
Christina Blume, Helin Dogan, … Felix Sahm·bioRxiv·May 11, 2021
- Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors
A. J. Patel, Y.-W. Wan, … T. J. Klisch·bioRxiv·Sep 10, 2019
- Detection of local growth patterns in longitudinally imaged low-grade gliomas
C. Gui, J. Kai, … J. F. Megyesi·bioRxiv·Apr 24, 2022
- Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
J. Z. Wang, V. Patil, … International Consortium on Meningiomas (ICOM)·Acta NeuropathologicaPeer-reviewed·Jul 1, 2023